儿科肺炎支原体感染患者的临床治疗分析

Analysis of clinical treatment of mycoplasma pneumoniae infection in children

目的:探讨儿科肺炎支原体感染患者的临床治疗效果。方法:2019年1月-2020年1月收治肺炎支原体感染患儿60例,随机分为两组,各30例。对照组应用红霉素(静脉滴注)治疗;观察组应用阿奇霉素治疗(静脉滴注+口服)。比较两组治疗效果。结果:观察组治疗总有效率高于对照组,且不良反应发生率低于对照组,差异有统计学意义(P<0.05);观察组咳嗽、湿啰音、发热等症状消失时间及住院时间均短于对照组,差异有统计学意义(P<0.05)。结论:对儿科肺炎支原体感染患者采用静脉滴注+口服阿奇霉素治疗的效果较好,具有较高的安全性,且能有效改善咳嗽、发热等症状,还可缩短住院时间。

Objective:To investigate the clinical treatment effect of mycoplasma pneumoniae infection in children.Methods:From January 2019 to January 2020,60 cases of children with mycoplasma pneumoniae infection were enrolled,they were randomly divided into two groups with 30 cases in each group.The control group was treated with erythromycin(intravenous drip).The observation group was treated with azithromycin(intravenous drip+oral).The therapeutic effects between the two groups was compared.Results:The total effective rate of treatment in the observation group was higher than that in the control group,the incidence of adverse reactions was lower than that of the control group,the differences were statistically significant(P<0.05).The disappearance time of cough,rales,fever and other symptoms and length of hospital stays in the observation group were shorter than those in the control group,the differences were statistically significant(P<0.05).Conclusion:The effect of intravenous drip and oral azithromycin treatment for pediatric patients with mycoplasma pneumoniae infection is better,it has high safety,it can not only effectively improve cough,fever and other symptoms,but also can shorten the length of hospital stays.